Literature DB >> 6423770

Mechanism of rabies virus entry into CER cells.

F Superti, M Derer, H Tsiang.   

Abstract

The early steps of rabies virus (CVS) infection in vitro were studied in chicken embryo-related (CER) cells. The infection was monitored by looking for specific intracytoplasmic viral inclusions using anti-rabies fluorescein isothiocyanate at 24 h after the addition of virus. The attachment of rabies virus to CER cells was shown to be inhibited by pretreatment of the cells with neuraminidase. These cells recovered their susceptibility to rabies virus infection 6 h after removal of the enzyme. Treatment of CER cells with neuraminidase after the viral attachment step did not inhibit infection. The subsequent delivery of infectious virions into acid prelysosomal vacuoles or lysosomes was studied using lysosomotropic agents. Ammonium chloride and chloroquine were used to prevent the virus fusion step thus preventing infection. Both drugs were shown to inhibit the early steps of infection, NH4Cl having a much earlier effect than chloroquine. The two drugs had no effect on the attachment step nor did NH4Cl inhibit virus multiplication. The use of metabolic inhibitors (2-deoxy-D-glucose and sodium azide) shows that the entry of rabies virus into CER cells does not require the involvement of cellular energy processes. In electron microscopy studies, the presence of rabies virus particles was detected in coated pits and coated vesicles as well as in uncoated vesicles, and later in lysosomes. These data indicate that the mechanism by which rabies virus enters CER cells is probably through adsorptive endocytosis and does not require the participation of cellular metabolic active processes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6423770     DOI: 10.1099/0022-1317-65-4-781

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  28 in total

1.  Identification and Characterization of a Small-Molecule Rabies Virus Entry Inhibitor.

Authors:  Venice Du Pont; Christoph Wirblich; Jeong-Joong Yoon; Robert M Cox; Matthias J Schnell; Richard K Plemper
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

2.  Reversible conformational changes and fusion activity of rabies virus glycoprotein.

Authors:  Y Gaudin; C Tuffereau; D Segretain; M Knossow; A Flamand
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

3.  Inhibition of rabies virus infection by a soluble membrane fraction from the rat central nervous system.

Authors:  C Conti; B Hauttecoeur; M J Morelec; B Bizzini; N Orsi; H Tsiang
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

4.  The effect of lipophilic amines on the growth of hepatitis A virus in Frp/3 cells.

Authors:  F Superti; L Seganti; N Orsi; M Divizia; R Gabrieli; A Panà
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

5.  Rabies virus infection of cultured rat sensory neurons.

Authors:  E Lycke; H Tsiang
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

6.  Role of phospholipids in rhabdovirus attachment to CER cells. Brief report.

Authors:  F Superti; L Seganti; H Tsiang; N Orsi
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

Review 7.  The cell biology of rabies virus: using stealth to reach the brain.

Authors:  Matthias J Schnell; James P McGettigan; Christoph Wirblich; Amy Papaneri
Journal:  Nat Rev Microbiol       Date:  2010-01       Impact factor: 60.633

8.  Ammonium chloride and chloroquine inhibit rabies virus infection in neuroblastoma cells. Brief report.

Authors:  H Tsiang; F Superti
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

9.  Uptake of rabies virus into epithelial cells by clathrin-mediated endocytosis depends upon actin.

Authors:  Silvia Piccinotti; Tomas Kirchhausen; Sean P J Whelan
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

10.  Mutations conferring resistance to neutralization by a soluble form of the neurotrophin receptor (p75NTR) map outside of the known antigenic sites of the rabies virus glycoprotein.

Authors:  Christelle Langevin; Christine Tuffereau
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.